Boston Trust Walden Corp Lowers Stake in ICU Medical, Inc. (NASDAQ:ICUI)

Boston Trust Walden Corp lowered its holdings in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 4.0% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 327,530 shares of the medical instruments supplier’s stock after selling 13,560 shares during the period. Boston Trust Walden Corp owned about 1.34% of ICU Medical worth $38,894,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Vanguard Group Inc. grew its holdings in shares of ICU Medical by 0.5% during the 1st quarter. Vanguard Group Inc. now owns 2,452,720 shares of the medical instruments supplier’s stock valued at $263,226,000 after purchasing an additional 11,991 shares during the last quarter. Schroder Investment Management Group grew its holdings in shares of ICU Medical by 35.8% during the 4th quarter. Schroder Investment Management Group now owns 433,852 shares of the medical instruments supplier’s stock valued at $43,272,000 after purchasing an additional 114,344 shares during the last quarter. Silvercrest Asset Management Group LLC grew its holdings in shares of ICU Medical by 109.4% during the 1st quarter. Silvercrest Asset Management Group LLC now owns 278,436 shares of the medical instruments supplier’s stock valued at $29,882,000 after purchasing an additional 145,485 shares during the last quarter. WCM Investment Management LLC grew its holdings in shares of ICU Medical by 5.8% during the 1st quarter. WCM Investment Management LLC now owns 256,946 shares of the medical instruments supplier’s stock valued at $27,575,000 after purchasing an additional 14,138 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its holdings in shares of ICU Medical by 4.3% during the 4th quarter. Dimensional Fund Advisors LP now owns 220,624 shares of the medical instruments supplier’s stock valued at $22,005,000 after purchasing an additional 9,196 shares during the last quarter. Institutional investors own 96.10% of the company’s stock.

Insider Activity

In other news, COO Christian B. Voigtlander sold 12,539 shares of ICU Medical stock in a transaction dated Thursday, May 30th. The shares were sold at an average price of $103.95, for a total transaction of $1,303,429.05. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In related news, COO Christian B. Voigtlander sold 12,539 shares of ICU Medical stock in a transaction dated Thursday, May 30th. The shares were sold at an average price of $103.95, for a total transaction of $1,303,429.05. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Vivek Jain sold 12,000 shares of ICU Medical stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $156.04, for a total transaction of $1,872,480.00. Following the transaction, the chief executive officer now directly owns 104,593 shares of the company’s stock, valued at $16,320,691.72. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 26,589 shares of company stock valued at $3,471,335. Corporate insiders own 6.70% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently commented on ICUI. Needham & Company LLC reaffirmed a “hold” rating on shares of ICU Medical in a report on Thursday, August 8th. Raymond James raised their price target on shares of ICU Medical from $135.00 to $158.00 and gave the stock an “outperform” rating in a report on Thursday, August 8th. Finally, KeyCorp raised their price target on shares of ICU Medical from $136.00 to $147.00 and gave the stock an “overweight” rating in a report on Thursday, August 8th. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $138.33.

ICU Medical Trading Up 0.2 %

ICU Medical stock traded up $0.32 during trading hours on Friday, reaching $158.44. The stock had a trading volume of 314,167 shares, compared to its average volume of 285,157. The company has a fifty day simple moving average of $125.56 and a 200-day simple moving average of $110.01. The stock has a market cap of $3.86 billion, a PE ratio of -64.67 and a beta of 0.69. The company has a debt-to-equity ratio of 0.76, a current ratio of 2.61 and a quick ratio of 1.09. ICU Medical, Inc. has a 52 week low of $78.28 and a 52 week high of $159.50.

ICU Medical (NASDAQ:ICUI) last announced its earnings results on Wednesday, August 7th. The medical instruments supplier reported $1.56 earnings per share for the quarter, beating analysts’ consensus estimates of $1.00 by $0.56. The firm had revenue of $596.50 million for the quarter, compared to analyst estimates of $556.64 million. ICU Medical had a negative net margin of 2.63% and a positive return on equity of 5.38%. The company’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.58 EPS. Analysts forecast that ICU Medical, Inc. will post 3.5 EPS for the current fiscal year.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.